Drugs Made In America Acquisition Corp. (DMAAU) Net Income towards Common Stockholders (2025)

Drugs Made In America Acquisition (DMAAU) has 1 years of Net Income towards Common Stockholders data on file, last reported at -$1.8 million in Q4 2025.

• Quarterly Net Income towards Common Stockholders changed N/A year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (changed N/A YoY) and the FY2025 annual result came in at $2.0 million, up 805.2% from the prior year.
• Net Income towards Common Stockholders retreated to -$1.8 million in Q4 2025, from $1.5 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $1.6 million in Q2 2025 to a low of -$1.8 million in Q4 2025.